Santana-Hernández, Sara
Suarez-Olmos, Jesús
Servitja, Sonia
Berenguer-Molins, Pau
Costa-Garcia, Marcel
Comerma, Laura
Rea, Anna
Perera-Bel, Julia
Menendez, Silvia
Arpí, Oriol
Bermejo, Begoña
Martínez, María Teresa
Cejalvo, Juan Miguel
Comino-Méndez, Iñaki
Pascual, Javier
Alba, Emilio
López-Botet, Miguel
Rojo, Federico
Rovira, Ana
Albanell, Joan
Muntasell, Aura http://orcid.org/0000-0003-2894-0486
Funding for this research was provided by:
Instituto de Salud Carlos III (PI19700328, PI22/00040, PI21/00002, PI18/00006)
Agència de Gestió d'Ajuts Universitaris i de Recerca (SGR 888, SGR 888, SGR 863, SGR 863)
Fundación Científica Asociación Española Contra el Cáncer (GCB15152947MELE, GCB15152947MELE)
Ministerio de Ciencia e Innovación (RED2022-134831-T)
H2020 Marie Skłodowska-Curie Actions (765104)
Article History
Received: 7 November 2023
Accepted: 29 November 2023
First Online: 3 January 2024
Declarations
:
: All healthy volunteers and patients gave written informed consent for the analysis of peripheral blood, serum and tumor biopsies for research purposes. Studies were conducted in accordance with the Declaration of Helsinki guidelines. Study protocol was approved by the local ethics committee (Clinical Research Ethics Committee, Parc de Salut Mar nº 2015/6038/I for healthy volunteers; nº 2013/5307, nº 2015/6038/I and 2019/8584/I for cancer patients).
: Not applicable.
: J. Albanell, report being advisory board member from Roche. J. Albanell, L. Comerma, report receiving other honoraria from Roche as speaker’s bureau or travel grants. The other authors declare no conflict of interest.